Document is current
Any future updates will be listed below
-
Authors
Wood, Jack I. https://orcid.org/0000-0001-6049-4020
Dulewicz, Maciej https://orcid.org/0000-0002-7149-017X
Szadziewska, Alicja https://orcid.org/0000-0002-8377-9309
Weiner, Sophia
Ge, Junyue https://orcid.org/0009-0005-9542-802X
Stringer, Katie
Desai, Sneha
Fenson, Lydia
Piotrowska, Diana
Brinkmalm, Gunnar https://orcid.org/0000-0001-6958-2393
Koutarapu, Srinivas
Hajar, Haady B. https://orcid.org/0009-0009-7311-7879
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Cummings, Damian M.
Savas, Jeffrey N. https://orcid.org/0000-0002-8173-5580
Edwards, Frances A.
Hanrieder, Jörg https://orcid.org/0000-0001-6059-198X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AG078796, AG080705)
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 14 August 2025
First Online: 1 September 2025
Competing interests
: H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. The remaining authors declare no competing interests.
